Browsing Tag
Glenmark Pharmaceuticals Limited
5 posts
Glenmark’s U.S. launch of Leucovorin Calcium for Injection: A strategic play in the generics arena
Find out how Glenmark Pharmaceuticals’ latest U.S. launch could reshape hospital generics in 2025. Will this move boost its global strategy?
Biologics race in Indian pharma: Can Glenmark’s AbbVie tie-up spark a broader innovation moment?
India’s biologics race heats up as Glenmark, Biocon, Sun Pharma, Dr. Reddy’s, and Lupin push beyond generics—see how each strategy stacks up.
Glenmark’s AbbVie deal: Can ISB 2001 make it India’s first true global biologics play?
Glenmark’s AbbVie deal for trispecific antibody ISB 2001 could redefine India’s role in global biologics—find out why this partnership matters now.
Glenmark Pharmaceuticals balances modest Q1 FY26 growth with innovation drive, global partnerships and robust pipeline ambitions
Glenmark’s Q1 FY26 results reveal modest growth but highlight strong specialty launches, AbbVie licensing deal, and a robust innovation pipeline.
Eris Lifesciences acquires nine Glenmark Pharmaceuticals dermatology brands in INR340.48 crore deal
Eris Lifesciences’ ₹340.48 crore purchase of nine Glenmark Pharmaceuticals dermatology brands reshapes India’s pharma market. See how it impacts strategy and growth.